Market Tracker

04/24 6:02pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.49
Delayed Data
As of Apr 24
 -0.02 / -1.32%
Today’s Change
0.97
Today|||52-Week Range
2.02
-21.16%
Year-to-Date

Today’s Trading

Previous close1.51
Today’s open1.50
Day’s range1.49 - 1.53
Volume291,349
Average volume (3 months)519,711
Market cap$224.0M
Dividend yield--
Data as of 4:02pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+47.92%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MDGNMedgenics Inc-0.15-1.64%
GALEGalena Biopharma Inc+0.02+1.40%
ALIMAlimera Sciences Inc-0.07-1.40%
ZGNXZogenix Inc-0.11-6.67%
Data as of 4:02pm ET, 04/24/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts